RNTX - Rein Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Rein Therapeutics, Inc. Common Stock
IPO Date: August 26, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $66.37M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.07 | 4.92%
Avg Daily Range (30 D): $0.03 | 4.03%
Avg Daily Range (90 D): $0.04 | 4.36%
Institutional Daily Volume
Avg Daily Volume: .34M
Avg Daily Volume (30 D): .37M
Avg Daily Volume (90 D): .38M
Trade Size
Avg Trade Size (Sh.): 225
Avg Trade Size (Sh.) (30 D): 287
Avg Trade Size (Sh.) (90 D): 265
Institutional Trades
Total Institutional Trades: 4
Avg Institutional Trade: $1.01M
Avg Institutional Trade (30 D): $1.35M
Avg Institutional Trade (90 D): $1.35M
Avg Institutional Trade Volume: .96M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.39M
Avg Closing Trade (30 D): $1.35M
Avg Closing Trade (90 D): $1.35M
Avg Closing Volume: 1.43M
 
News
May 18, 2026 @ 12:00 PM
Rein Therapeutics Announces Closing of $57.5 Milli...
Source: Na
May 1, 2026 @ 12:00 AM
Rein Therapeutics Announces Pricing of $50 Million...
Source: Na
Feb 9, 2026 @ 6:00 PM
Idiopathic Pulmonary Fibrosis Clinical Trials & Pi...
Source: Delveinsight
Aug 19, 2025 @ 12:00 PM
Rein Therapeutics Wins U.K. Approval to Launch Pha...
Source: Rein Therapeutics
Aug 14, 2025 @ 9:00 PM
Rein Therapeutics to Present Novel IPF Science and...
Source: Rein Therapeutics
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.1 $-.19 $-1.22
Diluted EPS $-.1 $-.19 $-1.22
Revenue $M $M $M
Gross Profit
Net Income / Loss $-6.38M $-5.84M $-31.97M
Operating Income / Loss $-6.08M $-5.23M $-32.66M
Cost of Revenue
Net Cash Flow $5.33M $M $.02M
PE Ratio